Justin M Balko Selected Research

Monoclonal Antibodies

11/2011	A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
5/2009	A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Justin M Balko Research Topics

Disease

95	Neoplasms (Cancer) 04/2024 - 11/2006
58	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2009
21	Triple Negative Breast Neoplasms 04/2024 - 03/2013
18	Melanoma (Melanoma, Malignant) 11/2023 - 01/2016
6	Bites and Stings (Sting) 12/2023 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 11/2006
5	Disease Progression 01/2021 - 01/2017
5	Lung Neoplasms (Lung Cancer) 05/2020 - 11/2006
4	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2009
4	Myocarditis (Carditis) 11/2022 - 11/2016
4	Pathologic Complete Response 01/2022 - 07/2013
3	COVID-19 01/2021 - 05/2020
3	Residual Neoplasm 01/2019 - 07/2012
3	Inflammation (Inflammations) 01/2019 - 01/2018
2	Genetic Risk Score 03/2024 - 09/2023
2	Colitis 03/2024 - 09/2023
2	Ulcerative Colitis 03/2024 - 09/2023
2	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 01/2019
1	Inflammatory Breast Neoplasms 01/2024
1	Overweight 11/2023
1	Neutropenia 11/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2023
1	Turcot syndrome 01/2023
1	Obesity 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Atherosclerosis 01/2022
1	Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

34	Immune Checkpoint InhibitorsIBA 04/2024 - 03/2016
20	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2006
17	LigandsIBA 04/2024 - 11/2006
15	Estrogen ReceptorsIBA 01/2023 - 04/2011
14	Hormones (Hormone)IBA 11/2023 - 04/2011
11	RNA (Ribonucleic Acid)IBA 01/2024 - 03/2013
11	InterferonsIBA 12/2023 - 01/2018
10	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2017 - 04/2011
9	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2006
9	Estrogens (Estrogen)FDA Link 02/2019 - 04/2011
9	Letrozole (Femara)FDA LinkGeneric 01/2019 - 04/2011
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 03/2009
7	CytokinesIBA 01/2021 - 11/2014
6	AntigensIBA 01/2023 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2014
6	Phenobarbital (Luminal)FDA Link 01/2023 - 08/2013
6	Aromatase InhibitorsIBA 08/2017 - 04/2011
5	B7-H1 AntigenIBA 11/2023 - 04/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2009
4	ChemokinesIBA 01/2022 - 01/2018
4	AlpelisibIBA 01/2019 - 07/2013
4	Fulvestrant (Faslodex)FDA Link 01/2019 - 11/2011
4	Tyrosine Kinase InhibitorsIBA 10/2017 - 11/2006
4	ErbB Receptors (EGF Receptor)IBA 08/2017 - 11/2006
4	Phosphotransferases (Kinase)IBA 01/2016 - 11/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2023 - 11/2016
3	HLA-DR Antigens (HLA-DR)IBA 10/2021 - 01/2016
3	AntibodiesIBA 10/2021 - 01/2016
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2021 - 01/2019
3	ParaffinIBA 01/2021 - 12/2014
3	human ERBB2 proteinIBA 01/2021 - 08/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2019 - 03/2009
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 03/2011
3	Lapatinib (GW572016)FDA Link 01/2019 - 07/2013
3	NVP-BKM120IBA 01/2019 - 04/2014
2	palbociclibIBA 11/2023 - 01/2019
2	ChromatinIBA 11/2023 - 09/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2020
2	protein phosphatase 4IBA 01/2022 - 07/2012
2	pembrolizumabIBA 10/2021 - 01/2019
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 09/2020
2	Nucleic AcidsIBA 01/2021 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2021 - 10/2017
2	130-nm albumin-bound paclitaxelIBA 11/2020 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2018
2	c-Mer Tyrosine KinaseIBA 01/2019 - 11/2014
2	NivolumabIBA 01/2019 - 11/2016
2	pertuzumabIBA 01/2019 - 08/2013
2	Blocking AntibodiesIBA 01/2019 - 11/2016
2	guadecitabineIBA 03/2018 - 01/2018
2	MethyltransferasesIBA 03/2018 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2015 - 07/2013
2	ClaudinsIBA 10/2013 - 08/2013
2	Monoclonal AntibodiesIBA 11/2011 - 05/2009
2	Tamoxifen FDA LinkGeneric 11/2011 - 04/2011
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Docetaxel (Taxotere)FDA Link 04/2024
1	ruxolitinibIBA 01/2024
1	TransposasesIBA 11/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Myosins (Myosin)IBA 11/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021

Therapy/Procedure

55	Therapeutics 04/2024 - 01/2009
29	Immunotherapy 04/2024 - 03/2016
16	Drug Therapy (Chemotherapy) 04/2024 - 07/2012
13	Neoadjuvant Therapy 01/2022 - 04/2011
3	Aftercare (After-Treatment) 11/2016 - 12/2014
2	Intravenous Administration 12/2023 - 10/2021